The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Preprints

The "under review" status pill and when a moderator applies it

N
NLoughranTL3Regular25 Feb 2026#1

Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that.

A question about how this site should cite something that has not been reviewed.

I want to reference a preprint in a maintained document. The convention I understand is to label the status in the sentence itself rather than in a footnote, and to record the date the version was checked.

Is that the whole convention, or is there a further step for the case where the preprint is later published with different numbers?

0 likes 5mo
LA
l.aguirreTL227 Feb 2026 · edited#2

The opening post describes the usual case. This is about the unusual one.

Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.

I am not the right person to answer the follow-up to this.

2 likes 5mo
MD
m.duarteTL228 Feb 2026#3

The most useful convention this subcategory has: state the status, state the version, state the date you checked. Three short clauses and the citation stays honest.

I would be interested in a counterexample if anyone has one.

13 likes 5mo
OV
o.vogelTL21 Mar 2026#4

Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has different numbers, and the changes are not random — they tend to be in the direction of a smaller effect and a more careful claim.

27 likes 5mo
RV
r.villalobosTL22 Mar 2026#5
l.aguirre, post #2: The opening post describes the usual case. This is about the unusual one. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I am not the right person to answer the follow-up to this. Go to post

I came in to disagree and I am leaving without a disagreement.

0 likes in reply to #2 5mo
RD
r.danquahTL23 Mar 2026#6

On post #2 — agreed on the reasoning, with one qualification.

Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.

Anyone who has looked at this more carefully, please correct the record.

0 likes 5mo
KF
k.fonsecaTL24 Mar 2026#7

Confirming post #4 from a second method, which matters more than confirming it from a second person.

Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but publication history is a difference worth noting.

Take the reasoning and check the arithmetic; I do not always get it right.

8 likes 5mo
KV
k.vanheckeTL25 Mar 2026#8

Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one.

The honest answer is that it depends, and here is what it depends on.

20 likes 5mo
W
WoodhouseTL2Member6 Mar 2026 · edited#9

Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.

28 likes 5mo
ZV
z.vogelTL27 Mar 2026#10
r.danquah, post #6: On post #2 — agreed on the reasoning, with one qualification. Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. Anyone who has looked at this more carefully, please correct the record. Go to post

What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report different results from updated analyses. The published version is not the same as the preprint.

0 likes in reply to #6 5mo
NK
n.krastevTL27 Mar 2026#11

Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.

Noting that the question and the thing people usually mean by it are different.

12 likes 5mo
DO
d.oyelaranTL3Pharmacist8 Mar 2026#12

The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting.

Two people can read the same figure differently here and both be reasonable.

4 likes 5mo
CT
c.tullochTL29 Mar 2026#13

Post #9 and I disagree about the size of the effect, not about the direction.

Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.

0 likes 5mo
K
KLindqvistTL4 Moderator10 Mar 2026 · edited#14
o.vogel, post #4: Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has different numbers, and the changes are not random — they tend to be in the direction of a smaller effect and a more careful claim. Go to post

That is clearer than the version I had in my head. Thank you.

0 likes in reply to #4 5mo
JI
j.iyerTL211 Mar 2026#15
d.oyelaran, post #12: The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Two people can read the same figure differently here and both be reasonable. Go to post

How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.

On balance I think that is right, and I would not bet much on it.

7 likes in reply to #12 5mo
BV
bias_varianceTL4Biostatistician11 Mar 2026#16

A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.

It took me longer than it should have to see that.

1 like 5mo
IA
id.almeidaTL212 Mar 2026#17

Post #13 put the caveat in the right place and I want to underline it.

Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.

0 likes 5mo
BD
baseline_driftTL2Analytical chemist13 Mar 2026#18
o.vogel, post #4: Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has different numbers, and the changes are not random — they tend to be in the direction of a smaller effect and a more careful claim. Go to post

Building on post #17 rather than restating it.

Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing which is which makes preprint reading easier.

25 likes in reply to #4 5mo
PA
p.amankwahTL213 Mar 2026#19

Agreed, and I will stop repeating the version of this I had been repeating.

24 likes 4mo
IC
i.coelhoTL214 Mar 2026#20

The arithmetic in post #17 is right; the assumption feeding it is the part to check.

Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.

The general case is well covered; this is the awkward specific one.

11 likes 4mo
CL
coldchain_liuTL3Regular15 Mar 2026#21

Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.

0 likes 4mo
AI
a.ilungaTL216 Mar 2026#22
r.danquah, post #6: On post #2 — agreed on the reasoning, with one qualification. Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. Anyone who has looked at this more carefully, please correct the record. Go to post

Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.

0 likes in reply to #6 4mo
AF
a.finnegan_rdTL2Dietitian16 Mar 2026#23
c.tulloch, post #13: Post #9 and I disagree about the size of the effect, not about the direction. Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it. Go to post

Picking up post #22: that is the part I would want checked first.

Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one.

9 likes in reply to #13 4mo
MN
m.nascimentoTL217 Mar 2026#24

Same experience here, different supplier, so it is at least not unique to one of them.

21 likes 4mo
VS
v.szaboTL3Analytical chemist18 Mar 2026#25

The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting.

That is the honest state of it as of this week.

30 likes 4mo
VK
v.kirchnerTL218 Mar 2026 · edited#26
o.vogel, post #4: Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has different numbers, and the changes are not random — they tend to be in the direction of a smaller effect and a more careful claim. Go to post

Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.

I checked the source rather than the summary, and they differ.

0 likes in reply to #4 4mo
SK
s.karlsen_rphTL3Pharmacist19 Mar 2026#27

Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having survived peer review. The trade-off is real.

5 likes 4mo
HV
h.vargaTL220 Mar 2026#28

Worth separating two things that post #25 runs together.

Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one.

15 likes 4mo
K
KLindqvistTL4 Moderator20 Mar 2026#29
a.finnegan_rd, post #23: Picking up post #22: that is the part I would want checked first. Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. Go to post

Building on post #26 rather than restating it.

A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.

I would put the burden of proof on the interesting explanation, not the dull one.

22 likes in reply to #23 4mo
KL
k.laurentTL221 Mar 2026#30
l.aguirre, post #2: The opening post describes the usual case. This is about the unusual one. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I am not the right person to answer the follow-up to this. Go to post

Post #28 put the caveat in the right place and I want to underline it.

Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as final.

Marking that as an opinion rather than a finding.

0 likes in reply to #2 4mo